Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferry Ossendorp

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
European Journal of Immunology|June 9, 2021
Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapyJannie Borst, Julia Busselaar, Douwe M T Bosma, et al.
Journal of Clinical Medicine|January 30, 2020
Preclinical and Clinical Evidence of Immune Responses Triggered in Oncologic Photodynamic Therapy: Clinical RecommendationsIrati Beltrán Hernández, Yingxin Yu, Ferry Ossendorp, et al.
International Archives of Allergy and Immunology|March 15, 2006
Ins and outs of dendritic cellsDanita H Schuurhuis, Nathalie Fu, Ferry Ossendorp, et al.
Frontiers in Immunology|May 15, 2018
Approaches to Improve Chemically Defined Synthetic Peptide VaccinesBrett J Hos, Elena Tondini, Sander I van Kasteren, et al.
Advances in Immunology|March 28, 2012
TLR ligand-peptide conjugate vaccines: toward clinical applicationGijs G P Zom, Selina Khan, Dmitri V Filippov, et al.
Cancer Immunology Research|February 2, 2017
Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide VaccinesEleni Maria Varypataki, Naomi Benne, Joke Bouwstra, et al.
Oncoimmunology|August 17, 2017
PD-L1 immune suppression in cancer: Tumor cells or host cells?Jan Willem Kleinovink, Thorbald van Hall, Ferry Ossendorp, et al.
Cancer Immunology Research|August 31, 2017
Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8<sup>+</sup> T CellsJan Willem Kleinovink, Marieke F Fransen, Clemens W Löwik, et al.
Cells|April 10, 2019
Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor ModelsHeng Sheng Sow, Jiang Ren, Marcel Camps, et al.
Cancer Chemotherapy and Pharmacology|September 10, 2017
The potential of multi-compound nanoparticles to bypass drug resistance in cancerC G Da Silva, Godefridus J Peters, Ferry Ossendorp, et al.
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
European Journal of Immunology|June 9, 2021
Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapyJannie Borst, Julia Busselaar, Douwe M T Bosma, et al.
Journal of Clinical Medicine|January 30, 2020
Preclinical and Clinical Evidence of Immune Responses Triggered in Oncologic Photodynamic Therapy: Clinical RecommendationsIrati Beltrán Hernández, Yingxin Yu, Ferry Ossendorp, et al.
International Archives of Allergy and Immunology|March 15, 2006
Ins and outs of dendritic cellsDanita H Schuurhuis, Nathalie Fu, Ferry Ossendorp, et al.
Frontiers in Immunology|May 15, 2018
Approaches to Improve Chemically Defined Synthetic Peptide VaccinesBrett J Hos, Elena Tondini, Sander I van Kasteren, et al.
Advances in Immunology|March 28, 2012
TLR ligand-peptide conjugate vaccines: toward clinical applicationGijs G P Zom, Selina Khan, Dmitri V Filippov, et al.
Cancer Immunology Research|February 2, 2017
Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide VaccinesEleni Maria Varypataki, Naomi Benne, Joke Bouwstra, et al.
Oncoimmunology|August 17, 2017
PD-L1 immune suppression in cancer: Tumor cells or host cells?Jan Willem Kleinovink, Thorbald van Hall, Ferry Ossendorp, et al.
Cancer Immunology Research|August 31, 2017
Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8<sup>+</sup> T CellsJan Willem Kleinovink, Marieke F Fransen, Clemens W Löwik, et al.
Cells|April 10, 2019
Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor ModelsHeng Sheng Sow, Jiang Ren, Marcel Camps, et al.
Cancer Chemotherapy and Pharmacology|September 10, 2017
The potential of multi-compound nanoparticles to bypass drug resistance in cancerC G Da Silva, Godefridus J Peters, Ferry Ossendorp, et al.
Pageof 17